What is Worldwide Primates?
Established in 1980, Worldwide Primates has cultivated a reputation as a foundational provider of high-quality primate research materials. The company serves as a vital link in the biomedical research ecosystem, supplying essential biological resources to research institutions and pharmaceutical developers. By maintaining rigorous standards and specialized infrastructure, the firm occupies a niche yet indispensable position in the life sciences market, facilitating advancements in drug discovery and clinical development through the provision of reliable, ethically sourced research models.
How much funding has Worldwide Primates raised?
Worldwide Primates has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Worldwide Primates
PPP
Public-Private Partnership
What's next for Worldwide Primates?
Following this late-stage financing, Worldwide Primates is positioned to optimize its operational efficiency and expand its research support capabilities. The strategic allocation of these funds will likely focus on enhancing facility standards, strengthening compliance frameworks, and scaling logistics to meet the evolving demands of the global biomedical community. As the company navigates the complexities of the current research landscape, this capital infusion provides the necessary liquidity to sustain long-term growth and maintain its competitive edge in a highly regulated industry.
See full Worldwide Primates company page
